IBIS
Pre-clinical- Indications
- COVID-19, SARS-CoV-1 infection, SARS-CoV-2 infection
Company intelligence / Profile preview
CVVT has established itself as a leading translational research center focused on infectious disease control through the development of rapid diagnostics, broad-spectrum antivirals, novel vaccines—including a nasal spray H5N1 avian flu vaccine—and enabling technology platforms. The center has demonstrated success in culturing previously uncultivable human rhinovirus C using innovative organoid models and is actively advancing multiple programs toward clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre for Virology, Vaccinology and Therapeutics.